New drug combo tested for Tough-to-Treat pancreatic cancer
Disease control
Completed
This study tested whether combining the drugs cabozantinib and pembrolizumab could help control metastatic pancreatic cancer. It involved 21 patients whose cancer had worsened despite standard treatments. The main goal was to see if the combination could delay cancer growth and i…
Phase: PHASE2 • Sponsor: Joseph Kim • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC